Home › Asset managers › Direxion Shares ETF Trust › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Direxion Shares ETF Trust voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
804 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Direxion Shares ETF Trust voted | Funds |
|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class III nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Timothy Walbert | Director Elections | Board | ABSTAIN | 1 |
| Natera, Inc. | 2026-06-11 | To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated. | Compensation | Board | AGAINST | 1 |
| Nicolet Bankshares, Inc. | 2026-05-18 | Approval, on a non-binding advisory basis, of the compensation paid to Nicolet's named executive officers. | Say-on-Pay | Board | AGAINST | 1 |
| Novavax, Inc. | 2026-06-18 | The approval, on an advisory basis, of the compensation of our Named Executive Officers. | Say-on-Pay | Board | AGAINST | 1 |
| Nurix Therapeutics, Inc. | 2026-05-15 | Election of Class III Directors: Arthur T. Sands, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Nurix Therapeutics, Inc. | 2026-05-15 | Election of Class III Directors: Paul M. Silva | Director Elections | Board | ABSTAIN | 1 |
| Nuvalent, Inc. | 2026-06-16 | Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Nuvation Bio Inc. | 2026-05-21 | Election of Directors: Robert Bazemore | Director Elections | Board | ABSTAIN | 1 |
| Nuvation Bio Inc. | 2026-05-21 | Election of Directors: Robert Mashal, M.D. | Director Elections | Board | ABSTAIN | 1 |
| ORIC Pharmaceuticals, Inc. | 2026-06-18 | To approve the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as amended and restated. | Compensation | Board | AGAINST | 1 |
| Ocular Therapeutix, Inc. | 2026-06-10 | To approve an advisory vote on named executive officer compensation. | Say-on-Pay | Board | AGAINST | 1 |
| Ocular Therapeutix, Inc. | 2026-06-10 | To elect two Class III directors, each to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Pravin U. Dugel, M.D. | Director Elections | Board | ABSTAIN | 1 |
| Omeros Corporation | 2026-06-18 | Approval of the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan. | Compensation | Board | AGAINST | 1 |
| Omeros Corporation | 2026-06-18 | Election of Directors: Diana T. Perkinson, M.D. | Director Elections | Board | AGAINST | 1 |
| Omeros Corporation | 2026-06-18 | Election of Directors: Thomas J. Cable | Director Elections | Board | AGAINST | 1 |
| PDD Holdings Inc. | 2025-12-19 | Elect Director Haifeng Lin | Director Elections | Board | AGAINST | 1 |
| PDD Holdings Inc. | 2025-12-19 | Elect Director Jiazhen Zhao | Director Elections | Board | AGAINST | 1 |
| PDD Holdings Inc. | 2025-12-19 | Elect Director Lei Chen | Director Elections | Board | AGAINST | 1 |
| Pacific Premier Bancorp, Inc. | 2025-07-21 | Approve, on an advisory (non-binding) basis, the merger-related compensation payments that will or may be paid to the named executive officers of Pacific Premier in connection with the transactions contemplated by the merger agreement. | Say-on-Pay | Board | AGAINST | 1 |
| Pacira Biosciences, Inc. | 2026-06-09 | Approval of our Amended and Restated 2011 Stock Incentive Plan. | Compensation | Board | AGAINST | 1 |
| Pacira Biosciences, Inc. | 2026-06-09 | Approval, on an advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 |
| Palvella Therapeutics, Inc. | 2026-06-10 | Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares. | Compensation | Board | AGAINST | 1 |
| Par Pacific Holdings, Inc. | 2026-04-30 | To approve the Par Pacific Holdings, Inc. 2026 Long-Term Incentive Plan. | Compensation | Board | AGAINST | 1 |
| Park National Corporation | 2026-04-27 | Approval of the Park National Corporation 2026 Long-Term Incentive Plan for Employees. | Compensation | Board | AGAINST | 1 |
| Parsons Corporation | 2026-04-14 | Election of Directors: Letitia A. Long | Director Elections | Board | ABSTAIN | 1 |
| Perspective Therapeutics, Inc. | 2026-05-27 | Election of Directors: Heidi Henson | Director Elections | Board | ABSTAIN | 1 |
| Perspective Therapeutics, Inc. | 2026-05-27 | Election of Directors: Robert Froman Williamson, III | Director Elections | Board | ABSTAIN | 1 |
| Phathom Pharmaceuticals, Inc. | 2026-05-19 | To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Steven Basta | Director Elections | Board | ABSTAIN | 1 |
| Phibro Animal Health Corporation | 2025-11-04 | Election of Class III Directors: Alejandro Bernal | Director Elections | Board | ABSTAIN | 1 |
| Phibro Animal Health Corporation | 2025-11-04 | Election of Class III Directors: E. Thomas Corcoran | Director Elections | Board | ABSTAIN | 1 |
| Phibro Animal Health Corporation | 2025-11-04 | Election of Class III Directors: Jack C. Bendheim | Director Elections | Board | ABSTAIN | 1 |
| Pilgrim's Pride Corporation | 2026-04-29 | A stockholder proposal to provide a political spending disclosure. | Other Social Issues | Shareholder | FOR | 1 |
| Pilgrim's Pride Corporation | 2026-04-29 | Election of Directors: JBS Directors: Andre Nogueira de Souza | Director Elections | Board | ABSTAIN | 1 |
| Pilgrim's Pride Corporation | 2026-04-29 | Election of Directors: JBS Directors: Gilberto Tomazoni | Director Elections | Board | ABSTAIN | 1 |
| Pilgrim's Pride Corporation | 2026-04-29 | Election of Directors: JBS Directors: Joanita Karoleski | Director Elections | Board | ABSTAIN | 1 |
| Pilgrim's Pride Corporation | 2026-04-29 | Election of Directors: JBS Directors: Joesley Mendonca Batista | Director Elections | Board | ABSTAIN | 1 |
| Pilgrim's Pride Corporation | 2026-04-29 | Election of Directors: JBS Directors: Wesley Mendonca Batista | Director Elections | Board | ABSTAIN | 1 |
| Pilgrim's Pride Corporation | 2026-04-29 | Election of Directors: JBS Directors: Wesley Mendonca Batista Filho | Director Elections | Board | ABSTAIN | 1 |
| PotlatchDeltic Corporation | 2026-01-27 | The PotlatchDeltic merger-related compensation proposal: A proposal to approve, on a non-binding advisory basis, the compensation that may be paid or become payable to the named executive officers of PotlatchDeltic in connection with the transactions contemplated by the merger agreement. | Say-on-Pay | Board | AGAINST | 1 |
| Precigen, Inc. | 2026-06-18 | Company Proposal - Election of Directors: Vinita Gupta | Director Elections | Board | AGAINST | 1 |
| Prime Medicine, Inc. | 2026-06-05 | To elect Michael Kelly and David Schenkein, M.D. as Class I Directors: David Schenkein, M.D. | Director Elections | Board | ABSTAIN | 1 |
| Protagonist Therapeutics, Inc. | 2026-06-17 | To approve the adoption of the Company's 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 |
| Protagonist Therapeutics, Inc. | 2026-06-17 | To elect the Class I director nominees named below to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dinesh V. Patel, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Qorvo, Inc. | 2025-08-13 | To approve, on an advisory basis, the compensation of our Named Executive Officers (as disclosed in the proxy statement). | Say-on-Pay | Board | AGAINST | 1 |
| REGENXBIO Inc. | 2026-05-29 | Election of three Class II Directors: Jean Bennett, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| REGENXBIO Inc. | 2026-05-29 | To approve a stock option exchange for our executive employees. | Compensation | Board | AGAINST | 1 |
| REGENXBIO Inc. | 2026-05-29 | To approve a stock option exchange for our non-executive employees. | Compensation | Board | AGAINST | 1 |
| RXO, Inc. | 2026-05-12 | Approval of an Amendment to the RXO, Inc. 2022 Omnibus Incentive Compensation Plan. | Compensation | Board | AGAINST | 1 |
| Recursion Pharmaceuticals, Inc. | 2026-06-17 | Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. | Say-on-Pay | Board | AGAINST | 1 |
| Recursion Pharmaceuticals, Inc. | 2026-06-17 | Election of Directors: Franziska Michor, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Recursion Pharmaceuticals, Inc. | 2026-06-17 | Election of Directors: Najat Khan, Ph.D. | Director Elections | Board | ABSTAIN | 1 |
| Red Cat Holdings, Inc. | 2026-06-18 | A non-binding advisory vote to approve the compensation of the Company's Named Executive Officers. | Say-on-Pay | Board | AGAINST | 1 |
| Red Cat Holdings, Inc. | 2026-06-18 | Election of five (5) Directors: Christopher R. Moe | Director Elections | Board | ABSTAIN | 1 |
| Red Cat Holdings, Inc. | 2026-06-18 | Election of five (5) Directors: General (R) Paul E. Funk II | Director Elections | Board | ABSTAIN | 1 |
| Red Cat Holdings, Inc. | 2026-06-18 | Election of five (5) Directors: Jeffrey M. Thompson | Director Elections | Board | ABSTAIN | 1 |
| Red Cat Holdings, Inc. | 2026-06-18 | Election of five (5) Directors: Joseph Freedman | Director Elections | Board | ABSTAIN | 1 |
| Red Cat Holdings, Inc. | 2026-06-18 | Election of five (5) Directors: Nicholas Liuzza Jr. | Director Elections | Board | ABSTAIN | 1 |
| Redwire Corporation | 2026-05-20 | Election of Class II Directors: Reggie Brothers | Director Elections | Board | ABSTAIN | 1 |
| Relay Therapeutics, Inc. | 2026-06-09 | To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Douglas S. Ingram | Director Elections | Board | ABSTAIN | 1 |
| RenaissanceRe Holdings Ltd. | 2026-05-05 | To approve the RenaissanceRe Holdings Ltd. 2026 Long-Term Incentive Plan. | Compensation | Board | AGAINST | 1 |
| Repligen Corporation | 2026-05-14 | Election of Directors: Carrie Eglinton Manner | Director Elections | Board | AGAINST | 1 |
| Repligen Corporation | 2026-05-14 | Election of Directors: Glenn P. Muir | Director Elections | Board | AGAINST | 1 |
| Repligen Corporation | 2026-05-14 | Election of Directors: Karen A. Dawes | Director Elections | Board | AGAINST | 1 |
| Replimune Group, Inc. | 2025-09-03 | To approve an amendment to Replimune Group, Inc.'s 2018 Omnibus Incentive Compensation Plan (the "Plan Amendment"). | Compensation | Board | AGAINST | 1 |
| Rezolute, Inc. | 2025-11-19 | To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers as disclosed in the Executive Compensation section of the Proxy Statement. | Say-on-Pay | Board | AGAINST | 1 |
| Rhythm Pharmaceuticals, Inc. | 2026-06-24 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. | Say-on-Pay | Board | AGAINST | 1 |
| Rigel Pharmaceuticals, Inc. | 2026-05-14 | To approve an amendment to our 2018 Equity Incentive Plan, as amended (the "Amended 2018 Plan"), to add an additional 500,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan. | Compensation | Board | AGAINST | 1 |
| Roblox Corporation | 2026-05-28 | Advisory Vote on the Compensation of our Named Executive Officers. | Say-on-Pay | Board | AGAINST | 1 |
| Roblox Corporation | 2026-05-28 | Election of Class II Directors: David Baszucki | Director Elections | Board | ABSTAIN | 1 |
| Roblox Corporation | 2026-05-28 | Election of Class II Directors: Gregory Baszucki | Director Elections | Board | ABSTAIN | 1 |
| Rocket Lab Corporation | 2025-08-27 | Election of Class I Directors: Jon Olson | Director Elections | Board | ABSTAIN | 1 |
| Rocket Lab Corporation | 2025-08-27 | Election of Class I Directors: Merline Saintil | Director Elections | Board | ABSTAIN | 1 |
| Rocket Lab Corporation | 2025-08-27 | To approve, on a non-binding advisory basis, the compensation of our named executive officers disclosed in the accompanying proxy statement. | Say-on-Pay | Board | AGAINST | 1 |
| Rocket Lab Corporation | 2026-05-20 | Election of Class II Director Nominee: To be elected for term expiring in 2029: Edward H. Frank | Director Elections | Board | ABSTAIN | 1 |
| Rocket Pharmaceuticals, Inc. | 2026-05-20 | The approval of the proposed stock option exchange program; and | Compensation | Board | AGAINST | 1 |
| SELLAS Life Sciences Group, Inc. | 2026-06-16 | The advisory approval of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 |
| Sable Offshore Corp. | 2026-06-10 | To elect one Class II director, Gregory Pipkin, to hold office until our 2029 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal: Gregory P. Pipkin | Director Elections | Board | ABSTAIN | 1 |
| Sana Biotechnology, Inc. | 2026-06-04 | To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Hans E. Bishop | Director Elections | Board | ABSTAIN | 1 |
| Sarepta Therapeutics, Inc. | 2026-06-04 | Advisory vote to approve, on a non-binding basis, named executive officer compensation | Say-on-Pay | Board | AGAINST | 1 |
| Schneider National, Inc. | 2026-04-30 | Approval of amended and restated 2017 Schneider National, Inc. Omnibus Incentive Compensation Plan. | Compensation | Board | AGAINST | 1 |
| Schneider National, Inc. | 2026-04-30 | The election to Schneider National's Board of Directors of the ten nominees named in the proxy statement. ELECTIONS OF DIRECTORS: Mary P. DePrey | Director Elections | Board | ABSTAIN | 1 |
| Scholar Rock Holding Corporation | 2026-06-04 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 1 |
| Scholar Rock Holding Corporation | 2026-06-04 | To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: David Hallal | Director Elections | Board | ABSTAIN | 1 |
| Science Applications International Corporation | 2026-06-03 | The approval of an amendment to the 2023 Equity Incentive Plan to increase the total number of authorized shares. | Compensation | Board | AGAINST | 1 |
| Septerna, Inc. | 2026-06-26 | To elect two Class II directors to our board of directors, each to serve until our 2029 Annual Meeting of Stockholders and until his or her respective successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Shalini Sharp | Director Elections | Board | ABSTAIN | 1 |
| Service Corporation International | 2026-05-06 | Election of Directors: Marcus A. Watts | Director Elections | Board | AGAINST | 1 |
| Service Corporation International | 2026-05-06 | To approve the 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 |
| Shift4 Payments, Inc. | 2026-06-12 | Approval of the Company's 2026 Employee Stock Purchase Plan. | Compensation | Board | AGAINST | 1 |
| Shift4 Payments, Inc. | 2026-06-12 | Election of Class III Directors: Jonathan Halkyard | Director Elections | Board | ABSTAIN | 1 |
| Shift4 Payments, Inc. | 2026-06-12 | Election of Class III Directors: Nancy Disman | Director Elections | Board | ABSTAIN | 1 |
| SiTime Corporation | 2026-05-29 | To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement. | Say-on-Pay | Board | AGAINST | 1 |
| Silicon Laboratories Inc. | 2026-04-23 | To approve amendments to the 2009 Stock Incentive Plan; and | Compensation | Board | AGAINST | 1 |
| SkyWest, Inc. | 2026-05-05 | A shareholder proposal regarding collective bargaining policy. | Human Rights or Human Capital/workforce | Shareholder | FOR | 1 |
| Snowflake Inc. | 2026-06-29 | Election of Class III Directors for terms expiring in 2029: Mark D. McLaughlin | Director Elections | Board | ABSTAIN | 1 |
| Snowflake Inc. | 2026-06-29 | Election of Class III Directors for terms expiring in 2029: Sridhar Ramaswamy | Director Elections | Board | ABSTAIN | 1 |
| Snowflake Inc. | 2026-06-29 | Election of Class III Directors for terms expiring in 2029: Teresa Briggs | Director Elections | Board | ABSTAIN | 1 |
| Snowflake Inc. | 2026-06-29 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 |
| Somnigroup International, Inc. | 2026-05-13 | ADVISORY VOTE TO APPROVE THE COMPENSATION OF NAMED EXECUTIVE OFFICERS; AND | Say-on-Pay | Board | AGAINST | 1 |
| Somnigroup International, Inc. | 2026-05-13 | APPROVAL OF AN AMENDMENT TO THE COMPANY'S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 500,000,000 TO 1,000,000,000. | Capital Structure | Board | AGAINST | 1 |
| Sonoco Products Company | 2026-04-15 | Advisory (non-binding) shareholder proposal - avoid brand damage from political spending. | Other Social Issues | Shareholder | FOR | 1 |
← Previous Page 7 of 9 Next →
← Back to Direxion Shares ETF Trust 2025-2026 overview
Built 2026-10-04 from SEC Form N-PX filings.